Cambridge Major Laboratories acquires ChemShop
Cambridge Major Laboratories has acquired ChemShop BV, a supplier of API development services, and plans to invest millions of dollars to expand the company's facilities.
Cambridge Major Laboratories (US) has acquired ChemShop BV (the Netherlands), a supplier of API development services. The newly combined company has over 140 employees at 3 sites in the US and Europe. ChemShop will adopt the name Cambridge Major Laboratories Europe.
All of ChemShop's management and personnel will continue to operate the business at the pre-existing Weert (Netherlands) facility, which includes R&D laboratories, GMP kilo lab suites, and a GMP pilot plant.
Cambridge Major plans to invest several million dollars to expand the European site to include more reactor capacity, laboratories, and expansion of the company's high potency API ("HPAPI") manufacturing capabilities. The planned expansion will commence immediately and be completed in the second half of 2008.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
